STK25 and neoplasm: Su et al. proposed in 2018 that STK25 negatively regulated tumor cell proliferation by downregulating the Golph3-dependent mTOR pathway and inhibiting glycolysis, which linked tumor metabolism with STK25 for the first time [8].